Trial Profile

The Lira Pump Trial. The Effects of Liraglutide in Patients With Insulin Pump Treated Type 1 Diabetes: A Randomized Placebo-Controlled Trial

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Liraglutide (Primary)
Indications Type 1 diabetes mellitus
Focus Therapeutic Use
Acronyms Lira Pump

Most Recent Events

15 Sep 2017 Primary endpoint of change in HbA1c at 26 week has been met, according to results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
13 Jun 2017 Results assessing changes in insulin dosing patterns during the study, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com